Insulet Corporation
PODD
$328.88
-$1.90-0.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.36B | 2.20B | 2.07B | 1.98B | 1.87B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.36B | 2.20B | 2.07B | 1.98B | 1.87B |
| Cost of Revenue | 703.80M | 651.00M | 625.90M | 595.20M | 569.70M |
| Gross Profit | 1.66B | 1.55B | 1.45B | 1.39B | 1.30B |
| SG&A Expenses | 1.01B | 978.20M | 917.30M | 869.10M | 815.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.97B | 1.86B | 1.76B | 1.67B | 1.59B |
| Operating Income | 393.80M | 340.70M | 308.80M | 318.60M | 283.40M |
| Income Before Tax | 270.70M | 293.40M | 300.20M | 296.70M | 267.50M |
| Income Tax Expenses | 34.60M | -108.80M | -118.10M | -124.20M | -127.80M |
| Earnings from Continuing Operations | 236.10 | 402.20 | 418.30 | 420.90 | 395.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 236.10M | 402.20M | 418.30M | 420.90M | 395.30M |
| EBIT | 393.80M | 340.70M | 308.80M | 318.60M | 283.40M |
| EBITDA | 467.25M | 424.40M | 389.60M | 396.70M | 358.90M |
| EPS Basic | 3.36 | 5.74 | 5.97 | 6.01 | 5.65 |
| Normalized Basic EPS | 3.43 | 3.01 | 2.69 | 2.76 | 2.47 |
| EPS Diluted | 3.29 | 5.56 | 5.79 | 5.88 | 5.54 |
| Normalized Diluted EPS | 3.30 | 2.85 | 2.56 | 2.62 | 2.35 |
| Average Basic Shares Outstanding | 280.95M | 280.62M | 280.31M | 280.00M | 279.70M |
| Average Diluted Shares Outstanding | 292.79M | 295.94M | 295.57M | 295.11M | 294.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |